Literature DB >> 22186140

miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

Gangxiong Huang1, Kazumasa Nishimoto, Zhichao Zhou, Dennis Hughes, Eugenie S Kleinerman.   

Abstract

The ability of osteosarcoma cells to form lung metastases has been inversely correlated to cell surface Fas expression. Downregulation of Fas allows osteosarcoma cells to circumvent FasL-mediated apoptosis upon entrance into the FasL(+) lung microenvironment. However, the mechanism of Fas regulation remains unclear. Here, we show that miRNA plays a role in the downregulation of Fas expression in osteosarcoma. Expression levels of several members of the miR-17-92 cluster including miR-20a and miR-19a were found to be higher in metastatic low-Fas-expressing LM7 cells than in the parental nonmetastatic high-Fas-expressing SAOS-2 cells. We also found an inverse correlation between Fas and miR-20a expression in all 8 cell lines derived from patient samples. Overexpression of miR-20a consistently resulted in the downregulation of Fas expression in SAOS-2 cells and thus in decreased sensitivity to FasL. Conversely, inhibiting miR-20a in LM7 cells increased Fas expression and their sensitivity to FasL. Mice injected with LM7 stably transfected with anti-miR-20a had fewer metastases than those with control plasmids. Taken together, our findings suggest that miR-20a, encoded by miR-17-92, downregulates Fas expression in osteosarcoma, thus contributing to the metastatic potential of osteosarcoma cells by altering the phenotype and allowing survival in the FasL(+) lung microenvironment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186140      PMCID: PMC3288434          DOI: 10.1158/0008-5472.CAN-11-1460

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  The CD95 receptor: apoptosis revisited.

Authors:  Marcus E Peter; Ralph C Budd; Julie Desbarats; Stephen M Hedrick; Anne-Odile Hueber; M Karen Newell; Laurie B Owen; Richard M Pope; Juerg Tschopp; Harald Wajant; David Wallach; Robert H Wiltrout; Martin Zörnig; David H Lynch
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

2.  MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.

Authors:  Thales Papagiannakopoulos; Alice Shapiro; Kenneth S Kosik
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

3.  Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.

Authors:  Nadezhda V Koshkina; Chand Khanna; Arnulfo Mendoza; Hui Guan; Lindsey DeLauter; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

4.  Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.

Authors:  Dmitriy Ovcharenko; Kevin Kelnar; Charles Johnson; Nan Leng; David Brown
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

5.  Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Amelia Cimino; Stefan Costinean; Calin Dan Dumitru; Brett Adair; Muller Fabbri; Hannes Alder; Chang Gong Liu; George Adrian Calin; Carlo Maria Croce
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

6.  MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.

Authors:  Mika Inomata; Hiroyuki Tagawa; Yong-Mei Guo; Yoshihiro Kameoka; Naoto Takahashi; Kenichi Sawada
Journal:  Blood       Date:  2008-10-21       Impact factor: 22.113

7.  Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells.

Authors:  Gangxiong Huang; Lisa Mills; Laura L Worth
Journal:  Mol Cancer Ther       Date:  2007-05       Impact factor: 6.261

8.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Authors:  Changchun Xiao; Lakshmi Srinivasan; Dinis Pedro Calado; Heide Christine Patterson; Baochun Zhang; Jing Wang; Joel M Henderson; Jeffrey L Kutok; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

9.  Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Authors:  Andrea Ventura; Amanda G Young; Monte M Winslow; Laura Lintault; Alex Meissner; Stefan J Erkeland; Jamie Newman; Roderick T Bronson; Denise Crowley; James R Stone; Rudolf Jaenisch; Phillip A Sharp; Tyler Jacks
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

10.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.

Authors:  Michaela Scherr; Letizia Venturini; Karin Battmer; Michael Schaller-Schoenitz; Daniel Schaefer; Iris Dallmann; Arnold Ganser; Matthias Eder
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971

View more
  86 in total

1.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  miR-20a facilitates metastasis of osteosarcoma cells to lung tissue.

Authors: 
Journal:  Bonekey Rep       Date:  2012-04-04

3.  MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.

Authors:  Lei Shen; Xiao-Dong Chen; Yao-Hui Zhang
Journal:  Tumour Biol       Date:  2013-10-15

4.  Assessment of Apoptosis Pathway in Peripheral Blood of Autistic Patients.

Authors:  Mohammad Mahdi Eftekharian; Alireza Komaki; Vahid Kholghi Oskooie; Amir Namvar; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2019-07-30       Impact factor: 3.444

5.  TET repression and increased DNMT activity synergistically induce aberrant DNA methylation.

Authors:  Hideyuki Takeshima; Tohru Niwa; Satoshi Yamashita; Takeji Takamura-Enya; Naoko Iida; Mika Wakabayashi; Sohachi Nanjo; Masanobu Abe; Toshiro Sugiyama; Young-Joon Kim; Toshikazu Ushijima
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages.

Authors:  Guoliang Zhang; Xi Liu; Wenfei Wang; Yi Cai; Shaoyuan Li; Qi Chen; Mingfeng Liao; Mingxia Zhang; Gucheng Zeng; Boping Zhou; Carl G Feng; Xinchun Chen
Journal:  Cell Cycle       Date:  2016-08-05       Impact factor: 4.534

Review 7.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

8.  miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.

Authors:  Jin Wang; Guoxing Xu; Feng Shen; Yifan Kang
Journal:  Tumour Biol       Date:  2014-01-22

9.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

10.  miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.

Authors:  Yiping Du; Mingxia Zhu; Xin Zhou; Zebo Huang; Jun Zhu; Jing Xu; Gongming Cheng; Yongqian Shu; Ping Liu; Wei Zhu; Tongshan Wang
Journal:  Tumour Biol       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.